Cite
HARVARD Citation
Kimura, T. et al. (2019). Phase I/II study of intermitted erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer (WJOG4708L). Japanese journal of clinical oncology. pp. 947-955. [Online].